Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Bram Roudijk"'
Publikováno v:
Health and Quality of Life Outcomes, Vol 22, Iss 1, Pp 1-16 (2024)
Abstract Purpose The 2016 EQ-5D-3L value set for Trinidad and Tobago (T&T) allows for the calculation of EQ-5D-5L values via the crosswalk algorithm. The 2016 value set was based on methods predating the EQ-VT protocol, now considered the gold standa
Externí odkaz:
https://doaj.org/article/807d5673878f4afaba18ff815f1ffe46
This open access book provides an essential guide to value sets for anyone working with EQ-5D-5L data. The EQ-5D-5L is one of the most widely used health related quality of life questionnaires around the world, with applications in clinical trials,
Autor:
Michał Jakubczyk, Stefan A. Lipman, Bram Roudijk, Richard Norman, Eleanor Pullenayegum, Yaling Yang, Ning Yan Gu, Elly Stolk
Publikováno v:
Value in Health, 26(2), 280-291. Elsevier Ltd.
Objectives: In cost-effectiveness analysis of health technologies, health state utilities are needed. They are often elicited with acomposite time trade-off (cTTO) method, particularly for the widely used EQ-5D-5L. Unfortunately, cTTO discriminatoryp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6314060fca675c74cddd83ec00e3d610
http://www.scopus.com/inward/record.url?scp=85147393260&partnerID=8YFLogxK
http://www.scopus.com/inward/record.url?scp=85147393260&partnerID=8YFLogxK
Autor:
Stefan A. Lipman, Brigitte A. B. Essers, Aureliano P. Finch, Ayesha Sajjad, Peep F. M. Stalmeier, Bram Roudijk
Publikováno v:
PharmacoEconomics, 40, 181-192. Adis
Pharmacoeconomics, 40(SUPPL 2), 181-192. Adis International Ltd
Pharmacoeconomics, 40(SUPPL 2), 181-192. Adis International Ltd
BACKGROUND AND OBJECTIVES: EQ-5D-Y-3L health states are commonly valued by asking adults to complete stated preference tasks, 'given their views about a 10-year-old child' (hereafter referred to as proxy 1). The use of this perspective has been a sou
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::676e19e11c7d90f06cd5428225c791e4
https://doi.org/10.1007/s40273-022-01202-1
https://doi.org/10.1007/s40273-022-01202-1
Publikováno v:
PharmacoEconomics. 40:123-127
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::64bfbf3117d8fd48578299a968247d67
https://doi.org/10.1007/s40273-022-01226-7
https://doi.org/10.1007/s40273-022-01226-7
Publikováno v:
PharmacoEconomics. 41:329-338
To investigate the effect of an extensive pilot phase in improving protocol compliance, face validity, reduction of interviewer effect and prediction errors in the composite time trade-off (cTTO) data elicited as part of the EQ-5D-5L valuation study
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dc9f6433f9d651fdfede409dfa348369
https://doi.org/10.1007/s40273-022-01208-9
https://doi.org/10.1007/s40273-022-01208-9
Autor:
Titi Sahidah Fitriana, Bram Roudijk, Fredrick Dermawan Purba, Jan J. V. Busschbach, Elly Stolk
Publikováno v:
PharmacoEconomics, 40, 157-167. Adis
Background and Objectives: Methods for estimating health values in adult populations are well developed, but lag behind in children. The EuroQol standard protocol to arrive at value sets for the youth version of the EQ-5D-Y-3L combines discrete choic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::18349ef52390dc33c9b9075b49c2eec3
https://doi.org/10.1007/s40273-022-01210-1
https://doi.org/10.1007/s40273-022-01210-1
Publikováno v:
PharmacoEconomics. 40:169-180
In Belgium, a value set for children and adolescents for a generic health-related quality-of-life measure is not available. To inform drug pricing and make resource allocation decisions for children and adolescents, national tax-payers' preferences f
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a31fa2b5f84a5fe0ad2cde103955f3fb
https://doi.org/10.1007/s40273-022-01187-x
https://doi.org/10.1007/s40273-022-01187-x
Autor:
Bram, Roudijk, Ayesha, Sajjad, Brigitte, Essers, Stefan, Lipman, Peep, Stalmeier, Aureliano Paolo, Finch
Publikováno v:
Pharmacoeconomics, 40(SUPPL 2), 193-203. Adis International Ltd
PharmacoEconomics, 40, 193-203. Adis
PharmacoEconomics, 40, 193-203. Adis
BACKGROUND AND OBJECTIVE: There is increasing interest in preference-accompanied measures of health for paediatric populations. The child-friendly EQ-5D version, EQ-5D-Y-3L, is one such instrument, but the lack of a Dutch value set prevents its use i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::af7dedc6d719bd0618559f2a6768fa7f
https://doi.org/10.1007/s40273-022-01192-0
https://doi.org/10.1007/s40273-022-01192-0
Autor:
Paul Revill, Mark Sculpher, Susan Griffin, Perez N. Ochanda, Fan Yang, Kenneth Katumba, Zhihao Yang, Bram Roudijk, Janet Seeley, Giulia Greco, Mohammed Lamorde
Publikováno v:
Pharmacoeconomics
Objective A ‘lite’ version of the EQ-5D-5L valuation protocol, which requires a smaller sample by collecting more data from each participant, was proposed and used to develop an EQ-5D-5L value set for Uganda. Methods Adult respondents from the ge
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::399c13ffe1b7cdf544af0b4395c6ca44
https://doi.org/10.1007/s40273-021-01101-x
https://doi.org/10.1007/s40273-021-01101-x